Cargando…
An Antibody-Aptamer-Hybrid Lateral Flow Assay for Detection of CXCL9 in Antibody-Mediated Rejection after Kidney Transplantation
Chronic antibody-mediated rejection (AMR) is a key limiting factor for the clinical outcome of a kidney transplantation (Ktx), where early diagnosis and therapeutic intervention is needed. This study describes the identification of the biomarker CXC-motif chemokine ligand (CXCL) 9 as an indicator fo...
Autores principales: | Seiler, Lisa K., Phung, Ngoc Linh, Nikolin, Christoph, Immenschuh, Stephan, Erck, Christian, Kaufeld, Jessica, Haller, Hermann, Falk, Christine S., Jonczyk, Rebecca, Lindner, Patrick, Thoms, Stefanie, Siegl, Julia, Mayer, Günter, Feederle, Regina, Blume, Cornelia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871475/ https://www.ncbi.nlm.nih.gov/pubmed/35204399 http://dx.doi.org/10.3390/diagnostics12020308 |
Ejemplares similares
-
Antibody-Mediated Rejection: Pathogenesis, Prevention, Treatment, and Outcomes
por: Blume, Olivia R., et al.
Publicado: (2012) -
HLA class II antibodies induce necrotic cell death in human endothelial cells via a lysosomal membrane permeabilization-mediated pathway
por: Aljabri, Abid, et al.
Publicado: (2019) -
Antibodies specific for nucleic acid modifications
por: Feederle, Regina, et al.
Publicado: (2017) -
Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection
por: Karason, Kristjan, et al.
Publicado: (2006) -
CXCL13 antibody for the treatment of autoimmune disorders
por: Klimatcheva, Ekaterina, et al.
Publicado: (2015)